Clinical potential of pacritinib in the treatment of myelofibrosis. (2015)

First Author: Duenas-Perez AB
Attributed to:  Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2040620715586527

PubMed Identifier: 26288713

Publication URI: http://europepmc.org/abstract/MED/26288713

Type: Journal Article/Review

Volume: 6

Parent Publication: Therapeutic advances in hematology

Issue: 4

ISSN: 2040-6207